Therapies based on small interfering RNAs (siRNAs) have recently hit the headlines with one drug effecting significant clinical improvements in patients suffering from motor neuron disease. Other therapies are also being developed and there can be no doubt regarding the potential for these new siRNA drugs. In this webinar we will explore how the European Patent Office (EPO) views inventions in this field and discuss obstacles innovators are likely to face when protecting their inventions.
Topics covered will include:
- Patent landscape
- How shall we claim it, and when?
- Where is practice going next?
- Is practice diverging in EP and US?